Dr. Simona O. Treidler, MD

Dr. Treidler practices at Neurology Associates of Stony Brook - HOPD in East Setauket, New York.

Dr. Treidler's NPI, 1376888008, was assigned on December 6, 2012. Dr. Treidler graduated from Carol Davila University of Medicine and Pharmacy in 1993. Dr. Treidler holds New York license 282831.

Dr. Treidler's primary practice is Neurology Associates of Stony Brook - HOPD, at 181 N Belle Mead Ave, East Setauket, NY 11733.

Dr. Treidler's primary practice is Neurology Associates of Stony Brook - HOPD in East Setauket, New York. Dr. Treidler is also affiliated with Long Island Jewish Medical Center. The medical group on file is Neurology Associates of Stony Brook. Dmand AI also links Dr. Treidler to 2 more hospitals, 3 medical groups, 2 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account. Dr. Treidler's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Treidler practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Treidler's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Treidler is licensed in New York.

CMS data shows 1,665 Medicare services from Dr. Treidler across 12 procedure codes in 2024, for 428 Medicare patients. Medicare paid $161,370 for them.

CMS counts 428 Medicare patients who saw Dr. Treidler in 2024. The largest group is 75 to 84, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Treidler's median patient age at 60, with 52% women.

In 2024, Dr. Treidler wrote 2,252 Medicare Part D claims for 252 patients. 75% of them were for generic drugs. CMS names the drug for 1,929 of them, across 54 drugs with 11 or more claims each, at $4,867,429 in total drug cost. In 2023, CMS named 1,444 claims across 41 drugs.

Dr. Treidler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Treidler as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Treidler, published from 2018 to 2022. The most frequent topics are Muscular Atrophy, Spinal, Neonatal Screening and New York. Dr. Treidler has published most often in Neurol Genet. Dr. Treidler's most frequent co-authors are Yaacov Anziska, MD, Claudia A. Chiriboga, MD and Emma Ciafaloni, MD.

Dmand AI links Dr. Treidler to 1 clinical trial. Conditions studied include Muscular Dystrophy, Duchenne and Muscular Dystrophies.

CMS Open Payments shows 69 general payments to Dr. Treidler from 16 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $537.

Dr. Treidler graduated from Carol Davila University of Medicine and Pharmacy in 1993.